152 related articles for article (PubMed ID: 25080209)
1. Ductal adenocarcinoma of the prostate: a Hong Kong case series.
Kan RW; Kan CF; Wong JH; Fu KK; Ng CF; Chan SW
Int Urol Nephrol; 2014 Nov; 46(11):2133-7. PubMed ID: 25080209
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].
Nakamura K; Terada N; Kobayashi T; Sugino Y; Yamasaki T; Matsui Y; Imamura M; Okubo K; Kamba T; Yoshimura K; Ogawa O
Hinyokika Kiyo; 2015 Dec; 61(12):487-91. PubMed ID: 26790762
[TBL] [Abstract][Full Text] [Related]
3. A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate.
Tu WH; Jensen K; Freiha F; Liao JC
Nat Clin Pract Urol; 2008 Jan; 5(1):55-8. PubMed ID: 18185514
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.
Packiam VT; Patel SG; Pariser JJ; Richards KA; Weiner AB; Paner GP; VanderWeele DJ; Zagaja GP; Eggener SE
Urology; 2015 Oct; 86(4):777-82. PubMed ID: 26196240
[TBL] [Abstract][Full Text] [Related]
5. A case study: ductal adenocarcinoma of the prostate.
Dziuba K
Urol Nurs; 2009; 29(6):422-4. PubMed ID: 20088233
[TBL] [Abstract][Full Text] [Related]
6. Prostatic Ductal Adenocarcinoma-A Rare Entity With Radiological Dilemma Demanding Endoscopic Biopsy.
Yadav SS; Baghel P; Tomar V; Agarwal N; Dhakad D
Urology; 2017 Oct; 108():e1-e2. PubMed ID: 28712887
[TBL] [Abstract][Full Text] [Related]
7. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
Yau TK; Chan A; Cheung PS
Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the diagnosis and management of ductal prostate cancer.
Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
[TBL] [Abstract][Full Text] [Related]
10. Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
Bardoscia L; Triggiani L; Sandri M; Francavilla S; Borghetti P; Dalla Volta A; Veccia A; Tomasini D; Buglione M; Valcamonico F; Simeone C; Berruti A; Magrini SM; Antonelli A
World J Urol; 2021 Apr; 39(4):1161-1170. PubMed ID: 32591899
[TBL] [Abstract][Full Text] [Related]
11. [A case of ductal adenocarcinoma of the prostate treated with endocrine therapy and radiation therapy].
Suzuki T; Shinbo H; Kurita Y; Furuse H; Mugiya S; Ozono S
Hinyokika Kiyo; 2011 May; 57(5):261-4. PubMed ID: 21743285
[TBL] [Abstract][Full Text] [Related]
12. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate.
Clouston D; Bolton D
BJU Int; 2012 Dec; 110 Suppl 4():22-4. PubMed ID: 23194119
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of prostatic adenocarcinoma with ductal features].
Yamashita R; Matsuzaki M; Matsui T; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
Nihon Hinyokika Gakkai Zasshi; 2008 Mar; 99(3):525-30. PubMed ID: 18404881
[TBL] [Abstract][Full Text] [Related]
14. Pure prostatic papillary adenocarcinoma with ductal features.
Yamashita S; Inaba Y; Soma F; Katayama Y
Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
[TBL] [Abstract][Full Text] [Related]
15. Locally Metastatic Ductal Adenocarcinoma of the Prostate: A Therapeutic and Prognostic Dilemma.
DiIenno N; Edwards DC; McGreen B; Levy J; Zheng H; Foote C; Nordsiek MF; Mapow B; May NR; Amster MI
Urology; 2018 Dec; 122():10-12. PubMed ID: 30171919
[No Abstract] [Full Text] [Related]
16. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract][Full Text] [Related]
17. [Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?].
Brock M; Martin W; Sommerer F; Noldus J
Urologe A; 2009 Jul; 48(7):770-3. PubMed ID: 19352617
[TBL] [Abstract][Full Text] [Related]
18. Patterns of metastases of prostatic ductal adenocarcinoma.
Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
[TBL] [Abstract][Full Text] [Related]
19. Emergency attendances and hospitalisations for complications after transrectal ultrasound-guided prostate biopsies: a five-year retrospective multicentre study.
Cheng KC; Lam WC; Chan HC; Ngo CC; Cheung MH; So HS; Lam KM
Hong Kong Med J; 2019 Oct; 25(5):349-355. PubMed ID: 31601774
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy.
Li CK; Tong BCY; You JHS
Int J Infect Dis; 2016 Feb; 43():7-12. PubMed ID: 26686941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
